ClinicalTrials.Veeva

Menu

Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors

Zhejiang University logo

Zhejiang University

Status

Enrolling

Conditions

Living Donor Liver Transplantation Recipients
Deceased Donor Liver Transplantation Recipients
Living Liver Donor

Treatments

Procedure: Living Donor Hepatectomy
Procedure: liver transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT07301853
2025-0793

Details and patient eligibility

About

This prospective cohort study aims to identify risk factors for postoperative adverse events in liver transplant recipients and living donors. By collecting comprehensive clinical data and conducting systematic long-term follow-up, the researchers intend to establish a specialized, standardized, and individualized follow-up management system. The ultimate goal is to optimize intervention strategies and improve patient prognosis and quality of life for both recipients and donors.

Enrollment

9,999 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients undergoing liver transplantation or living donor hepatectomy at the study center (living donor should be approved by the hospital ethics committee for living organ donation);
  2. Age 18 years or older;
  3. Willing to participate in the long-term follow-up management program;
  4. Signed informed consent form;

Exclusion criteria

  1. Patients undergoing combined organ transplantation
  2. Patients with severe mental illness or cognitive impairment who are unable to cooperate with follow-up assessments.
  3. Donors whose surgery is aborted intraoperatively for any reason.
  4. Unable or unwilling to comply with the long-term follow-up schedule.

Trial design

9,999 participants in 2 patient groups

recipients
Description:
A patient who received a new, healthy liver (or part of one from a living donor) to replace their own diseased liver
Treatment:
Procedure: liver transplantation
living donors
Description:
A healthy person who donated a portion of their healthy liver to someone with liver failure.
Treatment:
Procedure: Living Donor Hepatectomy

Trial contacts and locations

1

Loading...

Central trial contact

Wen Fang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems